Stay updated with breaking news from Aiolos Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GSK's experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects to make peak annual sales of 3...
By Najat Kantouar and Helena Smolak GSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than 3 billion pounds ...
Tha pharma giant, which is building out its respiratory portfolio, shared results of a late-stage clinical trial for its long-acting asthma medication
